(Q74432051)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

toxic epidermal necrolysis

10 November 2019

main subject

1 reference

P Paquet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E Jacob

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

P Damas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G E Piérard

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

652-655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

Toxic epidermal necrolysis

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

A case of toxic epidermal necrolysis treated with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Apoptosis is induced by anti-Fas antibody alone in cultured human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Fas ligand is expressed in normal skin and in some cutaneous malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

Fas ligand: a sensor for DNA damage critical in skin cancer etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0305-4179%2801%2900005-5

7 January 2021

10.1016/S0305-4179(01)00005-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11525863%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference